Synapse - Sarcoma Service

Results (953)

Patient-reported outcomes following treatment with vimseltinib for tenosynovial giant cell tumour in a phase 2 expansion study

Meeting Abstract

Blay, J. Y.; Gelderblom, H.; Rutkowski, P.; Wagner, A. J.; van de Sande, M.; Stacchiotti, S.; Le Cesne, A.; Palmerini, E.; Vallee, M.; Harrow, B.; more...
Value in Health (2022)

Fulltext@MSK | Save

Health state utility values and quality of life in patients receiving ripretinib in the phase 3 INVICTUS trial and a real-world evidence study in China

Meeting Abstract

Jones, R. L.; Blay, J. Y.; Chi, P.; Bauer, S.; Gelderblom, H.; Shen, L.; He, Y. L.; Heinrich, M. C.; Schöffski, P.; Zalcberg, J. R.; more...
Value in Health (2022)

Fulltext@MSK | Save

Inactivation mutations of KMT2C/D license a molecular "field effect" and prime the urothelium for tumorigenesis

Meeting Abstract

Wang, N.; Pachai, M. R.; Li, D.; Lee, C.; Warda, S.; Xie, G.; Qian, C.; Wong, W. P. E.; Yan, J.; Hu, W.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Meeting Abstract

Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C.; Cohen, S.; Park, J.; Hill, C.; Eng, K.; more...
Cancer Research (2022)

Fulltext@MSK | Save

PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor

Meeting Abstract

Chi, P.; Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets

Meeting Abstract

Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma on integrated genomic and epigenomic profiling

Meeting Abstract

Dermawan, J.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Villafania, L.; Benhamida, J.; Kelly, C.; Tap, W.; Boland, P.; more...
Journal of Molecular Diagnostics (2022)

Fulltext@MSK | Save

ZENYTH-ESO Substudy 1 (GSK3901961), cohort 1: A first-in-human study to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with non-small cell lung cancer

Meeting Abstract

Wermke, M.; Ullrich, R.; Yachnin, J.; Mielke, S.; Patel, R.; Yushak, M. L.; Schoenfeld, A. J.; Desai, J.; Altan, M.; D'angelo, S. P.; more...
Oncology Research and Treatment (2022)

Fulltext@MSK | Save

ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma, myxoid/round cell liposarcoma and nonsmall cell lung cancer [Substudy 1 (GSK3901961) and Substudy 2 (GSK3845097)]

Meeting Abstract

Ullrich, R.; Wermke, M.; Yachnin, J.; Mielke, S.; Patel, R.; Yushak, M. L.; Schoenfeld, A. J.; Desai, J.; Altan, M.; D'Angelo, S. P.; more...
Oncology Research and Treatment (2022)

Fulltext@MSK | Save

Comparison of a STIR- and T1-weighted-based radiomics model to differentiate between plexiform neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 (NF1)

Meeting Abstract

Ly, I.; Liu, T.; Cai, W.; Michaels, O.; Kwon, D.; Bredella, M.; Jordan, J.; Borcherding, D.; Boswell, D.; Burgess, C.; more...
Neuro-Oncology (2022)

Fulltext@MSK | Save